Skip to main content
. 2019 Jun 11;10:1257. doi: 10.3389/fimmu.2019.01257

Figure 1.

Figure 1

Experimental design and exercise capacity of mice from the different experimental groups. (A) C57BL/6 mice were infected with 103 Colombian strain T. cruzi trypomastigotes and treated during the chronic phase (6 months after infection) with 10 or 1 mg/kg of BA5 or benznidazole (100 mg/Kg), as indicated. (B,C) Distance run and time of exercise on a motorized treadmill. Values represent the means ± S.E.M. of 5 mice (naïve) or 10 mice (infected) per group. *P < 0.05 compared to vehicle-treated mice; #P < 0.05 compared to naive group. $P < 0.05 compared to benznidazole-treated group.